- Home
- ELEV vs AUST Comparison
ELEV vs AUST Comparison
Compare ELEV & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- AUST
- Stock Information
- Founded
- ELEV 2019
- AUST 2020
- Country
- ELEV United States
- AUST Canada
- Employees
- ELEV N/A
- AUST N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- ELEV Health Care
- AUST
- Exchange
- ELEV Nasdaq
- AUST Nasdaq
- Market Cap
- ELEV 22.6M
- AUST 19.0M
- IPO Year
- ELEV 2021
- AUST 2022
- Fundamental
- Price
- ELEV $0.38
- AUST $1.37
- Analyst Decision
- ELEV Hold
- AUST
- Analyst Count
- ELEV 6
- AUST 0
- Target Price
- ELEV $1.77
- AUST N/A
- AVG Volume (30 Days)
- ELEV 938.5K
- AUST 52.4K
- Earning Date
- ELEV 08-05-2025
- AUST 08-06-2025
- Dividend Yield
- ELEV N/A
- AUST N/A
- EPS Growth
- ELEV N/A
- AUST N/A
- EPS
- ELEV N/A
- AUST N/A
- Revenue
- ELEV N/A
- AUST N/A
- Revenue This Year
- ELEV N/A
- AUST N/A
- Revenue Next Year
- ELEV N/A
- AUST N/A
- P/E Ratio
- ELEV N/A
- AUST N/A
- Revenue Growth
- ELEV N/A
- AUST N/A
- 52 Week Low
- ELEV $0.22
- AUST $0.80
- 52 Week High
- ELEV $3.28
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- ELEV 54.73
- AUST 52.55
- Support Level
- ELEV $0.36
- AUST $1.32
- Resistance Level
- ELEV $0.38
- AUST $1.45
- Average True Range (ATR)
- ELEV 0.01
- AUST 0.08
- MACD
- ELEV -0.00
- AUST -0.00
- Stochastic Oscillator
- ELEV 53.93
- AUST 67.86
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).